Interventional Cardiology Journal Open Access

  • ISSN: 2471-8157
  • Journal h-index: 5
  • Journal CiteScore: 0.27
  • Journal Impact Factor: 0.13
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Dr. Gaetano Santulli

Dr. Gaetano Santulli
Principal investigator
Columbia University, United Kingdom

Biography

A physician-scientist, received his MD and PhD at the University of Naples ?Federico II?. Dr. Santulli completed his postdoctoral training at Columbia University Medical Center in New York City, supported by an American Heart Association (AHA) fellowship and a Scientist Development Grant. Dr. Santulli?s expertise comprises both clinical ? he is a cardiologist - and basic research topics, including hypertension, diabetes, heart failure, arrhythmias, vascular disease, microRNA, and mitochondrial pathophysiology. He serves on the editorial boards of numerous medical journals and he is Editor-in-Chief of the Journal of Cardiovascular Disease (JCvD). He authored more than 100 peer-reviewed publications and edited several medical books. He recently published ?Adrenal Glands: from pathophysiology to clinical evidence? and ?microRNA: from Molecular Biology to Clinical Practice?.

Research Interest

Hypertension, aging, diabetes, angiogenesis, myocardial infarction, heart failure, atrial fibrillation, cardiac hypertrophy, vascular disease, calcium handling, microRNA, cardiac resynchronization therapy, adrenergic receptors, vascular reactivity, Angioplasty, restenosis, interventional cardiology. thrombosis, excitation-contraction coupling, animal models, ischemia-reperfusion, arrhythmias, metabolic syndrome, endothelium, endothelial function, panic disorder, angiopoietin-like proteins, adrenal gland, calcium imaging, mTOR, drug eluting stents, pathophysiology, chronic obstructive pulmonary disease, insulin release, mitochondria, cardiac energetics, integrins, polymorphisms, insulin resistance.